epartment .D of .S Ju U s t ic e

.

Drug Enforcement Administra�on n

o

i t

a r t Special Testing and Research Laboratory is D in Third Quarter r m EMERGING THREAT REPORT 2017 u g d E t A nforcemen

The Special Tes�ng and Research Laboratory’s Emerging by DEA. This data is a quarterly snapshot of the new psychoac�ve An iden�fica�on is made when authen�cated reference material Trends Program compiled the data for this report through a substance market in the United States. is available for comparison. When reference material is not query of archived seizure and analysis informa�on from drug available, the drug evidence is iden�fied as “substance evidence analyzed by the Drug Enforcement Administra�on’s The term new psychoac�ve substance (NPS) describes a recently emerged unconfirmed”. A single unit of drug evidence may have mul�ple laboratory system. This data is representa�ve of drug drug that may pose a public health threat. This includes synthe�c sub-units. For the purposes of this document, each unit of drug evidence seized and analyzed in the date ranges annotated. , subs�tuted cathinones, , , evidence counts as one iden�fica�on regardless of the number This is not a comprehensive list of all new psychoac�ve tryptamines, benzodiazepines, and a variety of other chemical classes. Due of sub-units. Some seized drug evidence contains more than substances and is not representa�ve of all evidence analyzed to the recent increase in seizures, fentanyl is also included in this report. one ac�ve ingredient; therefore, more than one iden�fica�on can be made for a single unit. SYNTHETIC OPIOIDS/ CANNABINOIDS ANALGESICS CATHINONES

There were 54 synthetic identifications this reporting There were cathinone iden�fica�ons this repor�ng period. Fentanyl accounted for approximately 64% of the iden�fica�ons. 39 period. FUB-AMB accounted for 50% of the identifications. N-Ethylpentylone accounted for approximately of the Of the 219 fentanyl iden�fica�ons, fentanyl was found as the only 38% iden�fica�ons. Pentylone was the next most prominent cathinone controlled substance in approximately 44% of the iden�fica�ons and PB-22 1 was found in combina�on with in approximately 45% of the accoun�ng for 23% of the iden�fica�ons. FUB-AKB48 1 iden�fica�ons. U-47700 was the next most prominent opioid α-PPP 1 accoun�ng for approximately of the iden�fica�ons. FUB-144 7% 1 2 PPP = Pyrrolidinopropiophenone PHP = Pyrrolidinohexanophenone 5F-UR-144 α -PHP 3 PVP = Pyrrolidinovalerophenone 4 THF fentanyl 1 Dibutylone 4 ADB-FUBINACA � 3-Methylfentanyl 3 α-PVP 6 5F- MDMB- PINACA 11 Cyclopropylfentanyl 5 Other controlled substances identified with fentanyl this quarter include Pentylone 9 , , U-47700, FUB-AMB 27 Methoxyacetylfentanyl 7 , an d other N- Ethylpentylone 15 fentanyl-related compounds. Butyryl fentanyl 9 Acetylfentanyl 9 OTHER 4-ANPP 13 There were 5 instances of unconfirmed substances No NPS hallucinogens were iden�fied during the repor�ng period. Carfentanil 14 during this repor�ng period. Addi�onally, there were 7 4-FiBF 20 iden�fica�ons of 3-methoxy-PCP, 2 iden�fica�ons each of e�zolam and mitragynine, and 1 iden�fica�on each of 2-oxo-PCE and deschloroketamine. TRYPTAMINES Furanyl fentanyl 21 U- 47700 23 Questions about this data are welcome and may 219 There was 1 iden�fica�on of 4-OH-MET during Fentanyl be directed to the DEA Emerging Trends Program at the repor�ng period. 703-668-3300 or [email protected] FOR OFFICIAL USE ONLY